Ayala Pharmaceuticals Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • 2PO
  • (Cancelled)

  • Financing Rounds
  • 17

  • Investments
  • 1

Ayala Pharmaceuticals General Information

Description

Advaxis Inc is a clinical-stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate-Specific Antigen (PSA) associated with prostate cancer.

Contact Information

Formerly Known As
Advaxis, Great Expectations & Associates Inc
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 1007 North Orange Street
  • 4th Floor
  • Wilmington, DE 19802
  • United States
+1 (857)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Former Stock Listing
ADXS
Corporate Office
  • 1007 North Orange Street
  • 4th Floor
  • Wilmington, DE 19802
  • United States
+1 (857)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ayala Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Advaxis Inc is a clinical-stage biotechnology company operating in the United States. It focuses on the discovery, devel
Biotechnology
Wilmington, DE
15 As of 2022

South San Francisco, CA
 

Zug, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ayala Pharmaceuticals Competitors (154)

One of Ayala Pharmaceuticals’s 154 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Sorrento Therapeutics Formerly VC-backed San Diego, CA
ImmunityBio Formerly VC-backed San Diego, CA
You’re viewing 5 of 154 competitors. Get the full list »

Ayala Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ayala Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ayala Pharmaceuticals‘s full profile, request access.

Request a free trial

Ayala Pharmaceuticals Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Ayala Pharmaceuticals (Listeria Monocytogenes Immuno-Oncology And Related IP Assets) Wilmington, DE

Ayala Pharmaceuticals FAQs

  • When was Ayala Pharmaceuticals founded?

    Ayala Pharmaceuticals was founded in 1987.

  • Where is Ayala Pharmaceuticals headquartered?

    Ayala Pharmaceuticals is headquartered in Wilmington, DE.

  • What is the size of Ayala Pharmaceuticals?

    Ayala Pharmaceuticals has 15 total employees.

  • What industry is Ayala Pharmaceuticals in?

    Ayala Pharmaceuticals’s primary industry is Biotechnology.

  • Is Ayala Pharmaceuticals a private or public company?

    Ayala Pharmaceuticals is a Private company.

  • What is Ayala Pharmaceuticals’s current revenue?

    The current revenue for Ayala Pharmaceuticals is .

  • How much funding has Ayala Pharmaceuticals raised over time?

    Ayala Pharmaceuticals has raised $211M.

  • Who are Ayala Pharmaceuticals’s investors?

    Crede Capital Group, Arc Ventures (United States), and BioSight have invested in Ayala Pharmaceuticals.

  • Who are Ayala Pharmaceuticals’s competitors?

    CytomX Therapeutics, CRISPR Therapeutics, Inovio Pharmaceuticals, Sorrento Therapeutics, and ImmunityBio are some of the 154 competitors of Ayala Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »